GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 188 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,611,000 | -0.7% | 123,300 | +25.9% | 0.26% | -33.2% |
| Q1 2019 | $3,637,000 | +13.6% | 97,900 | +25.5% | 0.39% | +10.5% |
| Q4 2018 | $3,202,000 | +234.9% | 78,000 | +73.3% | 0.35% | +302.3% |
| Q3 2018 | $956,000 | -16.7% | 45,000 | -96.8% | 0.09% | +79.6% |
| Q2 2018 | $1,148,000 | +138.2% | 1,425,000 | +7996.6% | 0.05% | +88.5% |
| Q2 2017 | $482,000 | – | 17,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |